✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Mesoblast Limited

Common Name
Mesoblast
Country
Australia
Sector
Healthcare
Industry
Biotechnology
Employees
81
Ticker
MSB
Exchange
Australian Securities Exchange
Description
Mesoblast Limited is a biotechnology company specializing in the development of allogeneic, or off-the-shelf, cellular medicines intended for the treatment of severe and life-threatening inflammatory ...

Mesoblast's Board Composition Data

Explore Mesoblast's board composition data, including the total number of board members and their breakdown by executive/non-executive status, independence, and gender.

Metric2026-08-27
Total Board Member Count
8a
Executive Board Member Count
2a
Non-executive Board Member Count
6a
Independent Board Member Count
4a
Non-independent Board Member Count
4a
Female Board Member Count
2a
Male Board Member Count
6a
Non-binary Board Member Count
0a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Mesoblast’s Board Composition Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Mesoblast's 20-F 2026